Albireo Pharmaceutical's Series A Round

Albireo Pharmaceutical raised a round of funding on February 12, 2008.

Albireo is an independent Swedish biotechnology company, which aims to bring translational approaches to develop drugs that fulfil unmet medical needs in the gastrointestinal (GI) area. The team has a…

Articles about Albireo Pharmaceutical's Series A Round: